Focus on cardiometabolic risk factors.

Lancellotti, Patrizio

doi:10.1080/00015385.2023.2231702

Download

Article (Scientific journals)

Focus on cardiometabolic risk factors.

Lancellotti, Patrizio

2023 • In Acta Cardiologica, 78 (5), p. 515-518

Peer Reviewed verified by ORBi

Permalink
https://hdl.handle.net/2268/329452

DOI
10.1080/00015385.2023.2231702

PubMed
37458309

Files (1)Send to Details Statistics Bibliography Similar publications

Files

Full Text

Focus on cardiometabolic risk factors.pdf

Author postprint (946.81 kB)

Download

All documents in ORBi are protected by a user license.

Send to

RIS BibTex APA Chicago Permalink X Linkedin

Details

Keywords :

Humans; Cardiometabolic Risk Factors; Risk Factors; Cardiovascular Diseases/epidemiology/etiology

Disciplines :

Cardiovascular & respiratory systems

Author, co-author :

Lancellotti, Patrizio ; Centre Hospitalier Universitaire de Liège - CHU > > Service de cardiologie ; Maria Cecilia Hospital, Cotignola, and Anthea Hospital, Gruppo Villa Maria Care and Research, Bari, Italy.

Language :

English

Title :

Focus on cardiometabolic risk factors.

Publication date :

July 2023

Journal title :

Acta Cardiologica

ISSN :

0001-5385

eISSN :

1784-973X

Publisher :

Taylor & Francis, London, Gb

Volume :

Issue :

Pages :

515-518

Peer reviewed :

Peer Reviewed verified by ORBi

Available on ORBi :

since 18 March 2025

Statistics

Number of views

139 (0 by ULiège)

Number of downloads

86 (0 by ULiège)

More statistics

Scopus citations^®

Scopus citations^®
without self-citations

OpenCitations

OpenAlex citations

Bibliography

Jorissen W, Annemans L, Louis N, et al. Health economic modelling of diabetic kidney disease in patients with type 2 diabetes treated with canagliflozin in Belgium. Acta Clin Belg. 2022; 77 (6): 945–954. doi: 10.1080/17843286.2021.2015554.
Leiter LA, Fitchett DH, Gilbert RE, et al. Cardiometabolic risk in Canada: a detailed analysis and position paper by the cardiometabolic risk working group. Can J Cardiol. 2011; 27 (2): e1–e33. doi: 10.1016/j.cjca.2010.12.054.
Lancellotti P, Cosyns B. Highlights of acta cardiologica. Acta Cardiol. 2022; 77 (6): 469–470. doi: 10.1080/00015385.2022.2143092.
Menotti A, Puddu PE, Catasta G. Lifestyle behaviors predicting major cardiovascular diseases mortality in a practically extinct cohort of Middle-aged men followed-up for 61 years. Acta Cardiol. 2023; 78 (5): 578–585. doi: 10.1080/00015385.2022.2101876.
Ebrahimi H, Shayestefar M, Talebi SS, et al. Prevalence of hypertension and its associated factors among professional drivers: a population-based study. Acta Cardiol. 2023; 78 (5): 543–551. doi: 10.1080/00015385.2022.2045753.
Stremmel C, Vdovin N, Kellnar A, et al. Impact of moderate altitude exposure on cardiovascular risk. Acta Cardiol. 2021; 16: 1–4. doi: 10.1080/00015385.2021.1976449.
Prosecky R, Kunzova S, Kovacovicova P, et al. Association of anthropometric and body composition parameters with the presence of hypertension in the central european population: results from KardioVize 2030 study. Acta Cardiol. 2023; 78 (5): 614–622. doi: 10.1080/00015385.2023.2192153.
Humbert X, Licaj I, Fedrizzi S, et al. Relationship between lifestyle factors and hypertension: a cross-sectional analysis from the gubbio study. Acta Cardiol. 2023; 78 (5): 565–573. doi: 10.1080/00015385.2022.2088170.
Vynckier P, De Sutter J, De Pauw M, et al. Gender differences in risk factor management and pharmacological treatment among CHD patients: belgian results of the EUROASPIRE IV and EUROASPIRE V surveys. Acta Cardiol. 2023; 78 (5): 607–613. doi: 10.1080/00015385.2023.2169439.
Şaylık F, Akbulut T. Temporal relationship between serum calcium and triglyceride-glucose index and its impact on the incident of the acute coronary syndrome: a cross-lagged panel study. Acta Cardiol. 2023; 78 (5): 586–593. doi: 10.1080/00015385.2022.2106017.
Li H, Wei Y, Xi Y, et al. DR1-CSE/H2S pathway upregulates autophagy and inhibits H9C2 cells damage induced by high glucose. Acta Cardiol. 2023; 78 (5): 594–606. doi: 10.1080/00015385.2022.2119663.
Cheng X, Li Z, Yang M, et al. Association of HbA1c with carotid artery plaques in patients with coronary heart disease. Acta Cardiol. 2022; 31: 1–9.
Sprynger M, Lancellotti P. Comments on association of HbA1c with carotid artery plaques in patients with coronary heart disease. Acta Cardiol. 2023; 78 (5): 635–636.
Krohn JB, Neubauer C, Fischer S, et al. Optimisation of individual cardiovascular risk assessment in a german coronary artery disease cohort using a commercial test for genetic polymorphisms - a pilot study. Acta Cardiol. 2022; 3: 1–11.
Mungmunpuntipantip R, Wiwanitkit V. Comment on optimisation of individual cardiovascular risk assessment using a commercial test for genetic polymorphisms. Acta Cardiol. 2023; 78 (5): 634. doi: 10.1080/00015385.2022.2135239.
Deconinck A, Morra S, Glassée N, et al. Value of repeated measurements of lipoprotein (a) to assess cardiovascular risk: a retrospective study. Acta Cardiol. 2023; 78 (5): 536–542. doi: 10.1080/00015385.2022.2031377.
van de Borne P, Peeters A, Leone A, et al. Lipid-lowering therapy and risk-based LDL-C goal attainment in Belgium: DA VINCI observational study. Acta Cardiol. 2022; 20: 1–10. doi: 10.1080/00015385.2022.2030568.
Martens P, Mathieu C, Vanassche T. The use of glucagon-like-peptide-1 receptor agonist in the cardiology practice. Acta Cardiol. 2023; 78 (5): 552–564. doi: 10.1080/00015385.2022.2076307.
Boulmpou A, Patoulias D, Papadopoulos CE, et al. Meta-analysis of cardiovascular outcome trials assessing the impact of glucagon-like peptide-1 receptor agonists on major cardiac arrhythmias. Acta Cardiol. 2023; 78 (5): 519–524. doi: 10.1080/00015385.2022.2087839.
Nagarajan G, Govindan R, Poomarimuthu M, et al. The microbiome and rheumatic heart disease: current knowledge and future perspectives. Acta Cardiol. 2023; 78 (5): 525–533. doi: 10.1080/00015385.2023.2207933.
Köseoğlu C, Ramazan Öncel C. Possible effects of subclinical hypothyroidism on right ventricular myocardial work parameters. Acta Cardiol. 2023; 78 (5): 637. doi: 10.1080/00015385.2023.2214405.
Yurdam FS, Gürses E. Myocardial bridge and beta blockers: effect on left ventricular strain parameters. Acta Cardiol. 2023; 78 (5): 623–629. doi: 10.1080/00015385.2023.2209421.